Molecules/BLINATUMOMAB

BLINATUMOMAB

Molecular Identity

AntibodyApprovedFirst approved 2014

Mechanism of action: T cell surface glycoprotein CD3 cross-linking agent

Molecular Formula

0.00

Molecular Weight

g/mol

AMG-103AMG103BLINATUMOMABBLINCYTOMEDI-538MEDI538MT-103MT103

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to BLINATUMOMAB

Loading drug network...